MyHealthChecked Plc (LSE:MHC) — Market Cap & Net Worth
Market Cap & Net Worth: MyHealthChecked Plc (MHC)
MyHealthChecked Plc (LSE:MHC) has a market capitalization of $55.40K (GBX455.31 Million) as of May 3, 2026. Listed on the LSE stock exchange, this UK-based company holds position #31096 globally and #1186 in its home market, demonstrating a -2.78% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MyHealthChecked Plc's stock price GBX8.75 by its total outstanding shares 52035932 (52.04 Million). Analyse MyHealthChecked Plc cash conversion from operations to see how efficiently the company converts income to cash.
MyHealthChecked Plc Market Cap History: 2015 to 2025
MyHealthChecked Plc's market capitalization history from 2015 to 2025. Data shows change from $2.49 Million to $55.40K (-36.54% CAGR).
Index Memberships
MyHealthChecked Plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$928.08 Million | 0.01% | #409 of 722 |
Weight: MyHealthChecked Plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
MyHealthChecked Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MyHealthChecked Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
MyHealthChecked Plc's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.73 Million | $3.73K | -$1.10 Million | 464.66x | N/A |
| 2017 | $652.91K | $108.11K | -$2.34 Million | 6.04x | N/A |
| 2018 | $251.67K | $4.84K | -$2.81 Million | 52.02x | N/A |
| 2019 | $156.70K | $31.97K | -$2.15 Million | 4.90x | N/A |
| 2020 | $189.94K | $49.48K | -$3.76 Million | 3.84x | N/A |
| 2021 | $223.18K | $16.38 Million | $2.00 Million | 0.01x | 0.11x |
| 2022 | $149.58K | $22.31 Million | $1.52 Million | 0.01x | 0.10x |
| 2023 | $83.89K | $10.98 Million | -$159.00K | 0.01x | N/A |
| 2024 | $79.14K | $3.61 Million | -$1.79 Million | 0.02x | N/A |
Competitor Companies of MHC by Market Capitalization
Companies near MyHealthChecked Plc in the global market cap rankings as of May 3, 2026.
Key companies related to MyHealthChecked Plc by market ranking:
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #11160 globally with a market cap of $655.09 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11735 globally with a market cap of $587.05 Million USD.
- HCM II Acquisition Corp. Unit (NASDAQ:HONDU): Ranked #12289 globally with a market cap of $525.00 Million USD.
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #12774 globally with a market cap of $475.82 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #11160 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $655.09 Million | $10.02 |
| #11735 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #12289 | HCM II Acquisition Corp. Unit | NASDAQ:HONDU | $525.00 Million | $21.00 |
| #12774 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $475.82 Million | $10.14 |
MyHealthChecked Plc Historical Marketcap From 2015 to 2025
Between 2015 and today, MyHealthChecked Plc's market cap moved from $2.49 Million to $ 55.40K, with a yearly change of -36.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | GBX55.40K | -30.00% |
| 2024 | GBX79.14K | -5.66% |
| 2023 | GBX83.89K | -43.92% |
| 2022 | GBX149.58K | -32.98% |
| 2021 | GBX223.18K | +17.50% |
| 2020 | GBX189.94K | +21.21% |
| 2019 | GBX156.70K | -37.74% |
| 2018 | GBX251.67K | -61.45% |
| 2017 | GBX652.91K | -62.33% |
| 2016 | GBX1.73 Million | -30.48% |
| 2015 | GBX2.49 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of MyHealthChecked Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $55.40K USD |
| MoneyControl | $55.40K USD |
| MarketWatch | $55.40K USD |
| marketcap.company | $55.40K USD |
| Reuters | $55.40K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MyHealthChecked Plc
MyHealthChecked PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom. The company offers general health and energy profile blood test, bowel health rapid test, and stomach ulcer rapid test; nutritional health tests, such as intolerances and sensitivities DNA tests, vitamins and minerals DNA and profile blood tests, iron deficiency rapid test, a… Read more